DMT On The Brain
For nearly 50 years, a theory has lingered in the background of psychiatric research: that the human body might naturally produce a molecule capable of slowing down a brain enzyme linked to hallucinations. Now, researchers in the University of Florida College of Pharmacy are revisiting that forgotten science. Their goal is to identify and characterize a natural 'brake pedal' in the brain — one that could open the door to a new class of drugs for the production of endogenous DMT. The 'brake pedal' McCurdy’s team is investigating is a naturally occurring molecule that may slow the activity of an enzyme called indolethylamine N-methyltransferase, or INMT, which helps produce the powerful psychedelic compound dimethyltryptamine, or DMT, in the body. A 1977 study suggested tiny proteins in the body could block the enzyme, but the research stopped there. Nearly 50 years later, UF researchers are revisiting that early work in hopes of replicating it. “If we can characterize th...